N J Meropol1, P J Creaven, N J Petrelli. Show Affiliations » 1. Division of Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.
Abstract
Entities: Disease
Mesh: See more » Antineoplastic Combined Chemotherapy Protocols/adverse effectsAntineoplastic Combined Chemotherapy Protocols/metabolismAntineoplastic Combined Chemotherapy Protocols/therapeutic useAspartic Acid/administration & dosageAspartic Acid/analogs & derivativesCisplatin/analogs & derivativesColorectal Neoplasms/drug therapyColorectal Neoplasms/metabolismDiarrhea/chemically inducedDiarrhea/drug therapyDigestive System/drug effectsDrug Administration ScheduleFluorouracil/administration & dosageFluorouracil/metabolismGastrointestinal Agents/therapeutic useGranulocyte Colony-Stimulating Factor/therapeutic useGranulocyte-Macrophage Colony-Stimulating Factor/therapeutic useHumansInterferon-alpha/administration & dosageLeucovorin/administration & dosageOctreotide/therapeutic usePhosphonoacetic Acid/administration & dosagePhosphonoacetic Acid/analogs & derivativesProdrugs/therapeutic useRandomized Controlled Trials as TopicThymidylate Synthase/antagonists & inhibitorsTopoisomerase I Inhibitors
Substances: See more » Gastrointestinal AgentsInterferon-alphaProdrugsTopoisomerase I InhibitorsGranulocyte Colony-Stimulating FactorAspartic Acidsparfosic acidGranulocyte-Macrophage Colony-Stimulating FactorThymidylate SynthasePhosphonoacetic AcidCisplatinLeucovorinOctreotideFluorouracil
Year: 1995 PMID: 7570061
Source DB: PubMed Journal: Semin Oncol ISSN: 0093-7754 Impact factor: 4.929